Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells

被引:177
作者
Gredinger, E
Gerber, AN
Tamir, Y
Tapscott, SJ
Bengal, E
机构
[1] Technion Israel Inst Technol, Fac Med, Dept Biochem, Rappaport Inst Res Med Sci, IL-31096 Haifa, Israel
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
关键词
D O I
10.1074/jbc.273.17.10436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The differentiation of muscle cells is controlled by the MyoD family of transcription factors. This family is regulated by extracellular growth factors that transmit largely unknown signals into the cells. Here we show that the activity of extracellular signal-regulated protein kinase (ERK), a kinase that is part of the mitogenactivated protein kinase (MAPK) cascade, is low in myoblasts and is induced with the onset of terminal differentiation of C2 cells. ERK activity is also induced in fibroblasts that were modified to express MyoD, but not in the parental fibroblast cells. Thus, ERK induction is an intrinsic property of muscle cells. A specific MAPK kinase inhibitor (PD098059) that was added to C2 cells partially inhibited the fusion of myoblasts to multinucleated myotubes without affecting the expression of muscle-specific markers. This inhibitor blocked the induction of MyoD expression that normally takes place during terminal differentiation. Two lines of evidence suggest that the MAPK cascade induces the activity of MyoD: 1) the expression of constitutively activated forms of MEK1 or Raf1 enhanced the transcriptional activity of MyoD in 10T1/2 fibroblasts; and 2) the addition of PD098059 to fibroblast cells expressing a conditional MyoD-estrogen fusion protein significantly inhibited the expression of MyoD-responsive genes. Our results indicate that the MAPK pathway is activated in differentiating muscle cells and that it positively regulates the expression and activity of MyoD protein.
引用
收藏
页码:10436 / 10444
页数:9
相关论文
共 51 条
  • [1] RYANODINE RECEPTOR PROTEIN IS EXPRESSED DURING DIFFERENTIATION IN THE MUSCLE-CELL LINES BC3H1 AND C2C12
    AIREY, JA
    BARING, MD
    SUTKO, JL
    [J]. DEVELOPMENTAL BIOLOGY, 1991, 148 (01) : 365 - 374
  • [2] IDENTIFICATION OF THE SITES IN MAP KINASE KINASE-1 PHOSPHORYLATED BY P74(RAF-1)
    ALESSI, DR
    SAITO, Y
    CAMPBELL, DG
    COHEN, P
    SITHANANDAM, G
    RAPP, U
    ASHWORTH, A
    MARSHALL, CJ
    COWLEY, S
    [J]. EMBO JOURNAL, 1994, 13 (07) : 1610 - 1619
  • [3] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [4] EXPRESSION OF BACTERIAL BETA-GALACTOSIDASE IN ANIMAL-CELLS
    AN, GH
    HIDAKA, K
    SIMINOVITCH, L
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1982, 2 (12) : 1628 - 1632
  • [5] Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases
    Bennett, AM
    Tonks, NK
    [J]. SCIENCE, 1997, 278 (5341) : 1288 - 1291
  • [6] SIGNAL-TRANSDUCTION VIA THE MAP KINASES - PROCEED AT YOUR OWN RSK
    BLENIS, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) : 5889 - 5892
  • [7] TRANSFORMING GROWTH-FACTOR-BETA REPRESSES THE ACTIONS OF MYOGENIN THROUGH A MECHANISM INDEPENDENT OF DNA-BINDING
    BRENNAN, TJ
    EDMONDSON, DG
    LI, L
    OLSON, EN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) : 3822 - 3826
  • [8] ABERRANT REGULATION OF MYOD1 CONTRIBUTES TO THE PARTIALLY DEFECTIVE MYOGENIC PHENOTYPE OF BC3H1 CELLS
    BRENNAN, TJ
    EDMONDSON, DG
    OLSON, EN
    [J]. JOURNAL OF CELL BIOLOGY, 1990, 110 (04) : 929 - 937
  • [9] DIFFERENTIAL ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE IN RESPONSE TO BASIC FIBROBLAST GROWTH-FACTOR IN SKELETAL-MUSCLE CELLS
    CAMPBELL, JS
    WENDEROTH, MP
    HAUSCHKA, SD
    KREBS, EG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) : 870 - 874
  • [10] COFFER P, 1994, ONCOGENE, V9, P911